Belviq® lawsuits are now being filed!
The FDA has recalled Belviq® and Belviq® XR from the U.S. market.
Pancreatic Cancer
Colorectal Cancer
Lung Cancer
Breast Cancer
Other Cancers
and more...
Signs & Symptoms
Belviq® lawsuits are now being filed!
The FDA has recalled Belviq® and Belviq® XR from the U.S. market.FILL OUT THE FORM BELOW
TO GET YOUR FREE CLAIM REVIEW
You may be entitled to financial compensation!
Find Yourself a Lawyer That Will Fight For You and Your Rights!
Receive the Compensation
You Deserve!
FREE No Obligation
Consultation -
Pay Nothing!
Your Contact Information
and Your Claim are Confidential!
You may claim millions of dollars for your pain and suffering. You probably didn't know you could be owed money for your situation, and it is time to speak up! DON'T LET YOU OR YOUR FAMILY SUFFER in silence. If you have taken any of these, had any of these surgeries, submit your information for a FREE CLAIM REVIEW »
ABOUT BELVIQ®
Belviq® and its generic versions, lorcaserin are very popular weight-loss drugs used in the United States. It is sold and produced by Eisai Inc and was first approved by the FDA in 2012. Belviq® works by triggering chemical signals that make people want to eat less. Dosages vary between 10mg and 20mg tablets taken once daily. The recommended dose of Belviq® XR is 20 mg administered orally once daily.
Belviq® manufacturer Eisai, a Japanese company, has agreed to recall Belviq® from the market after the FDA performed an analysis of safety study results and found a very serious increased risk of several types of cancer in individuals who took Belviq®.
SIGNS & SYMPTOMS
After the FDA approved Belviq® in 2012 they required the manufacturer conduct a 5 year clinical trial to evaluate the risk of cardiovascular problems. The trial found that more patients taking the drug had a higher risk of developing the below types of cancer when compared to those taking a placebo.
- Pancreatic Cancer
- Colorectal Cancer
- Lung Cancer
- Breast Cancer
- Other Cancers
- and more...
TAKE ACTION
On February 13, 2020, the U.S. Food and Drug Administration (FDA) asked for Belviq®, Belviq® XR (lorcaserin) to be voluntarily removed from the US Market. The manufacturer, Eisai Inc has also agreed to recall Belviq® from the US market.Recent clinical trials conducted by the FDA show a possible increased risk of several types of cancer for individuals taking Belviq®.
With countless people now stricken with cancer after taking Belviq®, many are turning to the courts and filing a Belviq® lawsuit to hold Eisai Inc accountable for their reckless disregard for human health and willingness to put profit over people.
If you or a loved one have been diagnosed with cancer after taking Belviq® on a regular basis you need to speak up! You might be eligible for financial compensation for your pain and suffering. Don’t suffer in silence. Fill out a no-cost claim review to see if you are eligible to receive compensation. – complete the free and easy claim review form today.
IN THE NEWS
